Background and purpose:Hypoxia is a negative prognostic factor in head and neck squamous cell carcinoma (HNSCC). Although hypoxic volumes (HVs) may be targeted with dose-escalated radiotherapy (RT), hypoxia PET tracers such as FAZA are not widely used clinically. Moderate correlations between FDG PET and hypoxia PET tracers have been reported, but their spatial overlap remains unclear. This study investigated the spatial relationship between FDG-defined volumes and FAZA-defined HVs and evaluated its impact on dose escalation (DE) in HNSCC. Material and methods:Six HNSCC patients underwent FDG PET/CT for RT planning and further with FAZA PET/CT at the beginning, middle, and end of RT. Clinical FDG PET-positive volumes were delineated and additional FDG volumes were created as 30%, 40%, and 50% of the maximum SUV within the GTV (FDG SUV30/40/50). The HV within the GTV was defined as a FAZA signal ≥1.4x that of a reference tissue and rigidly transferred to the FDG PET/CT. DE plans to 78 Gy for the FAZA HV and FDG SUV40 volumes, respectively, were created and coverage metrics extracted. Results:FAZA HVs remained spatially stable while decreasing in size during RT. FDG-defined volumes were generally larger than the “true” FAZA HVs, yielding small false negative volumes (0.0-2.7cm3) but larger false positive volumes (1.2-21.4cm3). FAZA HVs were well-covered by FDG Clinical DE plans (V95% = [97-100%]).Conclusion:In this exploratory study for HNSCC patients, FDG-defined volumes adequately covered FAZA-defined HVs. FDG should be investigated further as practical surrogate for hypoxia-guided DE RT in HNSCC.